[Cross-resistance of tubercle bacilli (a review) (III) (author's transl)].
D000617:Aminoglycosides / Q000494:pharmacology; D000904:Antibiotics, Antitubercular / Q000494:pharmacology*; D002207:Capreomycin / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D007612:Kanamycin / Q000494:pharmacology; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D010303:Paromomycin / Q000031:analogs & derivatives / Q000494:pharmacology; D013307:Streptomycin / Q000494:pharmacology; D014756:Viomycin / Q000494:pharmacology
D000617:Aminoglycosides; D000904:Antibiotics, Antitubercular; D002207:Capreomycin; D007612:Kanamycin; D010303:Paromomycin; D013307:Streptomycin; D014756:Viomycin